BCL-2 and BCL-2 mutants SPR Assay Service

Surface Plasmon Resonance (SPR) technique for evaluating direct binding of small molecule inhibitors to BCL-2 and mutants F104L, D103Y, and G101V

Target Overview

Target

B-cell lymphoma-2

HGNC symbol

BCL2

Synonyms

BCL-2, PPP1R50, B-cell CLL/lymphoma 2, apoptosis regulator, BCL2 apoptosis regulator

Scientific information

P10415 (https://www.uniprot.org/uniprot/P10415)

Protein source

Produced at Reaction Biology

Screening location

Malvern, PA, USA

Further information

More information can be found on our website SPR Assay Services for Drug Discovery

Binding kinetics of ABT-737 to BCL-2 wildtype and mutants F104L, D103Y, and G101V

Binding kinetics of ABT-737 to BCL-2 wildtype and mutants F104L, D103Y, and G101V

The data was collected on a Biacore 8K using single-cycle kinetics. The data was analyzed using a 1:1 kinetic binding model.